These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 3010600)

  • 21. AgNOR- and PCNA-studies in astrocytomas of the optic nerve.
    Patt S; Giraldo M; Martin H
    Zentralbl Pathol; 1994 Mar; 140(1):83-7. PubMed ID: 7515678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microglia in gemistocytic astrocytomas.
    Geranmayeh F; Scheithauer BW; Spitzer C; Meyer FB; Svensson-Engwall AC; Graeber MB
    Neurosurgery; 2007 Jan; 60(1):159-66; discussion 166. PubMed ID: 17228265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliomas.
    Collins VP
    Cancer Surv; 1998; 32():37-51. PubMed ID: 10489622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression patterns of Wnt signaling component, secreted frizzled‑related protein 3 in astrocytoma and glioblastoma.
    Pećina-Šlaus N; Kafka A; Varošanec AM; Marković L; Krsnik Ž; Njirić N; Mrak G
    Mol Med Rep; 2016 May; 13(5):4245-51. PubMed ID: 27035837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recurrent astrocytoma versus primary astrocytoma: a comparative study of morphological changes of 32 cases].
    Hu Y; Hang Z; Ouyang M
    Hua Xi Yi Ke Da Xue Xue Bao; 1994 Mar; 25(1):91-3. PubMed ID: 8070783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences between phosphotyrosine accumulation and Neu/ErbB-2 receptor expression in astrocytic proliferative processes. Implications for glial oncogenesis.
    Kristt DA; Yarden Y
    Cancer; 1996 Sep; 78(6):1272-83. PubMed ID: 8826951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer-assisted discrimination of glioblastomas.
    Scarpelli M; Montironi R; Thompson D; Bartels PH
    Anal Quant Cytol Histol; 1997 Oct; 19(5):369-75. PubMed ID: 9349896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma.
    Leins A; Riva P; Lindstedt R; Davidoff MS; Mehraein P; Weis S
    Cancer; 2003 Dec; 98(11):2430-9. PubMed ID: 14635078
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Histological and molecular classification of gliomas].
    Figarella-Branger D; Colin C; Coulibaly B; Quilichini B; Maues De Paula A; Fernandez C; Bouvier C
    Rev Neurol (Paris); 2008; 164(6-7):505-15. PubMed ID: 18565348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic analysis of primary brain tumors.
    McComb RD; Burger PC
    Neurol Clin; 1985 Nov; 3(4):711-28. PubMed ID: 3001488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of Ki-67 labeling index as an adjunct to the histopathological diagnosis and grading of astrocytomas.
    Thotakura M; Tirumalasetti N; Krishna R
    J Cancer Res Ther; 2014; 10(3):641-5. PubMed ID: 25313753
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunohistochemical study of proliferation index of astrocytomas classified by new histopathological grading].
    Takekawa Y; Sawada T; Sakurai I
    Rinsho Byori; 1995 May; 43(5):483-6. PubMed ID: 7783368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical analysis of metallothionein in astrocytic tumors in relation to tumor grade, proliferative potential, and survival.
    Hiura T; Khalid H; Yamashita H; Tokunaga Y; Yasunaga A; Shibata S
    Cancer; 1998 Dec; 83(11):2361-9. PubMed ID: 9840536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropathology of malignant gliomas.
    Bruner JM
    Semin Oncol; 1994 Apr; 21(2):126-38. PubMed ID: 8153659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of MG-160, a FGF binding medial Golgi sialoglycoprotein, in brain tumors: an index of malignancy in astrocytomas.
    Yamaguchi F; Morrison RS; Gonatas NK; Takahashi H; Sugisaki Y; Teramoto A
    Int J Oncol; 2003 May; 22(5):1045-9. PubMed ID: 12684670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Grading of astrocytomas and oligodendrogliomas].
    Kolles H; Niedermayer I; Feiden W
    Pathologe; 1998 Jul; 19(4):259-68. PubMed ID: 9746910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Quantitative histological observations in gliomas (author's transl)].
    Martin H; Schmidt D; Heim I; Scholze K; Tanner G
    Zentralbl Allg Pathol; 1980; 124(1-2):31-9. PubMed ID: 6251667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ultrastructural pathology of glial brain tumors revisited: a review.
    Liberski PP; Kordek R
    Ultrastruct Pathol; 1997; 21(1):1-31. PubMed ID: 9029763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.